Key facts
- Joaquin Duato believes curing certain cancers is an achievable goal within the next decade.
- He also stated that transforming other cancers into chronic diseases is achievable in the same timeframe.
Joaquin Duato, the CEO of Johnson & Johnson, has expressed optimism regarding advancements in cancer treatment, stating that curing certain types of cancer and managing others as chronic diseases are achievable goals within the next decade.
Duato's remarks highlight a significant target for the pharmaceutical and healthcare industry, suggesting a transformative period ahead for cancer care.